SEC Form 4 · accession 0001375852-17-000004

ICU MEDICAL INC/DE · ICUI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer,

Period of report

Jul 10, 2017

Accepted (ET)

Jul 11, 2017 · 8:12 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000883984

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jul 10, 2017	X	2,998	$46.53	A	9,050	D
Common Stock^F1	Jul 10, 2017	S	2,698	$170.0355	D	6,352	D
Common Stock^F2	Jul 10, 2017	S	300	$171.00	D	6,052	D
Common Stock	Jul 11, 2017	X	20,774	$46.53	A	26,826	D
Common Stock^F2	Jul 11, 2017	S	20,774	$170.00	D	6,052	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F4,F3	$46.53	Jul 10, 2017	X	2,998	D	—	Feb 1, 2022	Common Stock	0	20,774	D
Non-Qualified Stock Option (right to buy)^F4,F3	$46.53	Jul 11, 2017	X	20,774	D	—	Feb 1, 2022	Common Stock	0	0	D

F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $170.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2All shares sold were sold at the exact price disclosed.
F3Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
F4Transaction is the exercise of a derivative security; see Column 2.